245 related articles for article (PubMed ID: 21358357)
1. Whole genome analysis from microdissected tissue revealed adult supratentorial grade II-III gliomas are divided into clinically relevant subgroups by genetic profile.
Hirose Y; Sasaki H; Miwa T; Ohba S; Ikeda E; Abe M; Ikeda S; Kobayashi M; Kawase T; Hasegawa M; Yoshida K
Neurosurgery; 2011 Aug; 69(2):376-90. PubMed ID: 21358357
[TBL] [Abstract][Full Text] [Related]
2. Subgrouping of gliomas on the basis of genetic profiles.
Hirose Y; Sasaki H; Abe M; Hattori N; Adachi K; Nishiyama Y; Nagahisa S; Hayashi T; Hasegawa M; Yoshida K
Brain Tumor Pathol; 2013 Oct; 30(4):203-8. PubMed ID: 23604523
[TBL] [Abstract][Full Text] [Related]
3. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.
Marko NF; Prayson RA; Barnett GH; Weil RJ
Genomics; 2010 Jan; 95(1):16-24. PubMed ID: 19835948
[TBL] [Abstract][Full Text] [Related]
4. World Health Organization grade II-III astrocytomas consist of genetically distinct tumor lineages.
Hattori N; Hirose Y; Sasaki H; Nakae S; Hayashi S; Ohba S; Adachi K; Hayashi T; Nishiyama Y; Hasegawa M; Abe M
Cancer Sci; 2016 Aug; 107(8):1159-64. PubMed ID: 27196377
[TBL] [Abstract][Full Text] [Related]
5. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
Dehais C; Laigle-Donadey F; Marie Y; Kujas M; Lejeune J; Benouaich-Amiel A; Pedretti M; Polivka M; Xuan KH; Thillet J; Delattre JY; Sanson M
Cancer; 2006 Oct; 107(8):1891-7. PubMed ID: 16986124
[TBL] [Abstract][Full Text] [Related]
6. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
7. Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.
Weller M; Weber RG; Willscher E; Riehmer V; Hentschel B; Kreuz M; Felsberg J; Beyer U; Löffler-Wirth H; Kaulich K; Steinbach JP; Hartmann C; Gramatzki D; Schramm J; Westphal M; Schackert G; Simon M; Martens T; Boström J; Hagel C; Sabel M; Krex D; Tonn JC; Wick W; Noell S; Schlegel U; Radlwimmer B; Pietsch T; Loeffler M; von Deimling A; Binder H; Reifenberger G
Acta Neuropathol; 2015 May; 129(5):679-93. PubMed ID: 25783747
[TBL] [Abstract][Full Text] [Related]
8. Genomic aberrations in diffuse low-grade gliomas.
Dahlback HS; Gorunova L; Brandal P; Scheie D; Helseth E; Meling TR; Heim S
Genes Chromosomes Cancer; 2011 Jun; 50(6):409-20. PubMed ID: 21412929
[TBL] [Abstract][Full Text] [Related]
9. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
Nutt CL; Mani DR; Betensky RA; Tamayo P; Cairncross JG; Ladd C; Pohl U; Hartmann C; McLaughlin ME; Batchelor TT; Black PM; von Deimling A; Pomeroy SL; Golub TR; Louis DN
Cancer Res; 2003 Apr; 63(7):1602-7. PubMed ID: 12670911
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.
Gravendeel LA; Kouwenhoven MC; Gevaert O; de Rooi JJ; Stubbs AP; Duijm JE; Daemen A; Bleeker FE; Bralten LB; Kloosterhof NK; De Moor B; Eilers PH; van der Spek PJ; Kros JM; Sillevis Smitt PA; van den Bent MJ; French PJ
Cancer Res; 2009 Dec; 69(23):9065-72. PubMed ID: 19920198
[TBL] [Abstract][Full Text] [Related]
11. Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization.
Weber RG; Sabel M; Reifenberger J; Sommer C; Oberstrass J; Reifenberger G; Kiessling M; Cremer T
Oncogene; 1996 Sep; 13(5):983-94. PubMed ID: 8806688
[TBL] [Abstract][Full Text] [Related]
12. Molecular classification defines 4 prognostically distinct glioma groups irrespective of diagnosis and grade.
Mur P; Mollejo M; Hernández-Iglesias T; de Lope ÁR; Castresana JS; García JF; Fiaño C; Ribalta T; Rey JA; Meléndez B
J Neuropathol Exp Neurol; 2015 Mar; 74(3):241-9. PubMed ID: 25668564
[TBL] [Abstract][Full Text] [Related]
13. High-resolution genome-wide mapping of genetic alterations in human glial brain tumors.
Bredel M; Bredel C; Juric D; Harsh GR; Vogel H; Recht LD; Sikic BI
Cancer Res; 2005 May; 65(10):4088-96. PubMed ID: 15899798
[TBL] [Abstract][Full Text] [Related]
14. [Histological and molecular classification of gliomas].
Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
[TBL] [Abstract][Full Text] [Related]
15. Using gene expression profiling to identify a prognostic molecular spectrum in gliomas.
Shirahata M; Oba S; Iwao-Koizumi K; Saito S; Ueno N; Oda M; Hashimoto N; Ishii S; Takahashi JA; Kato K
Cancer Sci; 2009 Jan; 100(1):165-72. PubMed ID: 19038000
[TBL] [Abstract][Full Text] [Related]
16. [Update on the molecular biology of gliomas: towards a pathomolecular classification of gliomas].
Idoate MA; Echeveste J
Rev Neurol; 2007 Feb 16-28; 44(4):217-24. PubMed ID: 17311212
[TBL] [Abstract][Full Text] [Related]
17. [Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour].
Born PW; Broholm H; Laursen H
Ugeskr Laeger; 2006 Oct; 168(44):3813-6. PubMed ID: 17118240
[TBL] [Abstract][Full Text] [Related]
18. Molecular voting for glioma classification reflecting heterogeneity in the continuum of cancer progression.
Fuller GN; Mircean C; Tabus I; Taylor E; Sawaya R; Bruner JM; Shmulevich I; Zhang W
Oncol Rep; 2005 Sep; 14(3):651-6. PubMed ID: 16077969
[TBL] [Abstract][Full Text] [Related]
19. Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.
Cimino PJ; Zager M; McFerrin L; Wirsching HG; Bolouri H; Hentschel B; von Deimling A; Jones D; Reifenberger G; Weller M; Holland EC
Acta Neuropathol Commun; 2017 May; 5(1):39. PubMed ID: 28532485
[TBL] [Abstract][Full Text] [Related]
20. Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis.
Carlsson E; Krohn K; Ovaska K; Lindberg P; Häyry V; Maliniemi P; Lintulahti A; Korja M; Kivisaari R; Hussein S; Sarna S; Niiranen K; Hautaniemi S; Haapasalo H; Ranki A
Genes Chromosomes Cancer; 2013 Feb; 52(2):191-201. PubMed ID: 23097141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]